Luke Sergott
Stock Analyst at Barclays
(4.81)
# 507
Out of 5,090 analysts
804
Total ratings
51.9%
Success rate
15.5%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Reiterated: Buy | $23 → $26 | $21.29 | +22.12% | 24 | Oct 30, 2026 | |
| ILMN Illumina | Reiterated: Sell | $200 | $235.99 | -15.25% | 53 | Oct 30, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $440 → $500 | $412.62 | +21.18% | 13 | Oct 30, 2026 | |
| AVTR Avantor | Reiterated: Sell | $15 → $16 | $16.05 | -0.31% | 48 | Oct 29, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $175 | $211.36 | -17.20% | 43 | Oct 28, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $300 | $267.33 | +12.22% | 51 | Oct 28, 2026 | |
| LH Labcorp Holdings | Reiterated: Hold | $330 → $380 | $361.39 | +5.15% | 19 | Oct 28, 2026 | |
| RGEN Repligen | Reiterated: Buy | $225 | $176.94 | +27.16% | 14 | Oct 28, 2026 | |
| QGEN Qiagen | Downgraded: Hold | $55 → $53 | $50.22 | +5.54% | 21 | Oct 27, 2026 | |
| DGX Quest Diagnostics | Reiterated: Buy | $260 | $251.82 | +3.25% | 22 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $625 → $675 | $652.01 | +3.53% | 12 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $260 | $232.23 | +11.96% | 49 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $750 → $775 | $697.00 | +11.19% | 48 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $195 | $174.87 | +11.51% | 35 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $70 | $57.07 | +22.66% | 21 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 → $9 | $11.02 | -18.33% | 37 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $220 | $178.80 | +23.04% | 21 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,575 → $1,700 | $1,674.81 | +1.50% | 11 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $475 | $414.30 | +14.65% | 17 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.25 | $2.61 | -52.02% | 28 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $115 → $160 | $157.00 | +1.91% | 35 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $18.15 | +21.21% | 44 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $215 | $152.78 | +40.73% | 42 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $110 | $70.11 | +56.90% | 36 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $460 → $500 | $462.72 | +8.06% | 36 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $330 | $359.41 | -8.18% | 21 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $42 | $4.88 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $221.08 | n/a | 1 | Jan 18, 2023 |
Fortrea Holdings
Oct 30, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $21.29
Upside: +22.12%
Illumina
Oct 30, 2026
Reiterated: Sell
Price Target: $200
Current: $235.99
Upside: -15.25%
West Pharmaceutical Services
Oct 30, 2026
Reiterated: Buy
Price Target: $440 → $500
Current: $412.62
Upside: +21.18%
Avantor
Oct 29, 2026
Reiterated: Sell
Price Target: $15 → $16
Current: $16.05
Upside: -0.31%
ICON Public Limited Company
Oct 28, 2026
Reiterated: Hold
Price Target: $175
Current: $211.36
Upside: -17.20%
IQVIA Holdings
Oct 28, 2026
Reiterated: Buy
Price Target: $300
Current: $267.33
Upside: +12.22%
Labcorp Holdings
Oct 28, 2026
Reiterated: Hold
Price Target: $330 → $380
Current: $361.39
Upside: +5.15%
Repligen
Oct 28, 2026
Reiterated: Buy
Price Target: $225
Current: $176.94
Upside: +27.16%
Qiagen
Oct 27, 2026
Downgraded: Hold
Price Target: $55 → $53
Current: $50.22
Upside: +5.54%
Quest Diagnostics
Oct 23, 2026
Reiterated: Buy
Price Target: $260
Current: $251.82
Upside: +3.25%
Oct 23, 2026
Reiterated: Hold
Price Target: $625 → $675
Current: $652.01
Upside: +3.53%
Oct 22, 2026
Reiterated: Buy
Price Target: $255 → $260
Current: $232.23
Upside: +11.96%
Oct 22, 2026
Reiterated: Buy
Price Target: $750 → $775
Current: $697.00
Upside: +11.19%
Oct 7, 2026
Reiterated: Buy
Price Target: $175 → $195
Current: $174.87
Upside: +11.51%
Oct 7, 2026
Reiterated: Buy
Price Target: $58 → $70
Current: $57.07
Upside: +22.66%
Oct 7, 2026
Reiterated: Hold
Price Target: $7.5 → $9
Current: $11.02
Upside: -18.33%
Oct 7, 2026
Reiterated: Buy
Price Target: $200 → $220
Current: $178.80
Upside: +23.04%
Oct 7, 2026
Reiterated: Buy
Price Target: $1,575 → $1,700
Current: $1,674.81
Upside: +1.50%
Oct 7, 2026
Reiterated: Buy
Price Target: $340 → $475
Current: $414.30
Upside: +14.65%
Oct 7, 2026
Reiterated: Sell
Price Target: $1.25
Current: $2.61
Upside: -52.02%
Oct 7, 2026
Reiterated: Hold
Price Target: $115 → $160
Current: $157.00
Upside: +1.91%
Oct 7, 2026
Reiterated: Buy
Price Target: $22
Current: $18.15
Upside: +21.21%
Oct 7, 2026
Reiterated: Buy
Price Target: $112 → $215
Current: $152.78
Upside: +40.73%
Oct 7, 2026
Reiterated: Buy
Price Target: $52 → $110
Current: $70.11
Upside: +56.90%
Oct 7, 2026
Reiterated: Buy
Price Target: $460 → $500
Current: $462.72
Upside: +8.06%
Sep 24, 2026
Reiterated: Buy
Price Target: $300 → $330
Current: $359.41
Upside: -8.18%
Jun 12, 2023
Reiterated: Hold
Price Target: $35 → $42
Current: $4.88
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $221.08
Upside: n/a